Asthma medication receives new warning / Diane S. Aschenbrenner

By:

Aschenbrenner, Diane S

Series: American Journal of Nursing. 115 : 1, page 22-23 Publication details: January 2015ISSN:

0002-936X

Subject(s):

Summary: The Food and Drug Administration has revised the warnings in the labeling of omalizumab (Xolair), a drug used in the treatment of allergic asthma. Omalizumab's labeling now warns that the drug may carry a slightly elevated risk of cardiovascular complications. Omalizumab is administered every two to four weeks as a subcutaneous injection to patients with moderate-to-severe persistent, allergic asthma and an elevated IgE level and whose allergic asthma symptoms aren't well controlled with corticosteroids.

Item type: Articles

Average rating: 0.0 (0 votes)

Holdings
Current library	Call number	Status	Date due	Barcode
Manila Tytana Colleges Library REFERENCE SECTION	Bound (Browse shelf(Opens below))	Not For Loan

Browsing Manila Tytana Colleges Library shelves, Shelving location: REFERENCE SECTION Close shelf browser (Hides shelf browser)

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	Bound The aca continues to run the gauntlet /	Bound Stories to watch in 2015 /	Bound Controversy over pelvic examinations /	Bound Asthma medication receives new warning /	Bound New treatment for opioid-induced constipation /	Bound Long-term outcomes after repair of congenital heart defects : part 1 /	Bound Cordon sanitaire	Next

The Food and Drug Administration has revised the warnings in the labeling of omalizumab (Xolair), a drug used in the treatment of allergic asthma. Omalizumab's labeling now warns that the drug may carry a slightly elevated risk of cardiovascular complications. Omalizumab is administered every two to four weeks as a subcutaneous injection to patients with moderate-to-severe persistent, allergic asthma and an elevated IgE level and whose allergic asthma symptoms aren't well controlled with corticosteroids.

Nursing

There are no comments on this title.

to post a comment.

Asthma medication receives new warning / Diane S. Aschenbrenner

Browsing Manila Tytana Colleges Library shelves, Shelving location: REFERENCE SECTION Close shelf browser (Hides shelf browser)

Manila Tytana Colleges Library | Metropolitan Park, Pres. Diosdado Macapagal Blvd., Pasay City, 1300 Tel.(+63-2) 859-0826 | E-mail library@mtc.edu.ph

Manila Tytana Colleges Library | Metropolitan Park, Pres. Diosdado Macapagal Blvd., Pasay City, 1300
Tel.(+63-2) 859-0826 | E-mail library@mtc.edu.ph